公开(公告)号：US20200172978A1

公开(公告)日：2020-06-04

申请号：US16785790

申请日：2020-02-10

Applicant: THE SECRETARY OF STATE FOR DEFENCE

Inventor： PHILLIPPA MARIA SPENCER ,  ROMAN ANTONI LUKASZEWSKI ,  LAURA CRADDOCK ,  HELEN ELERI JONES

IPC: C12Q1/6883 ,  G16B25/00

Abstract: The present invention provides kits, methods, and apparatus for analysing a biological sample from an animal to predict (pre-symptomatically) and monitor the development of sepsis, utilising biomarker signatures, and especially biomarker signatures capable of providing a mean predictive accuracy of at least 92% to differentiate development of sepsis from non-sepsis.

公开(公告)号：US20170009297A1

公开(公告)日：2017-01-12

申请号：US15117923

申请日：2015-01-09

Applicant: THE SECRETARY OF STATE FOR DEFENCE

Inventor： PHILLIPPA MARIA SPENCER ,  ROMAN ANTONI LUKASZEWSKI ,  LAURA CRADDOCK ,  HELEN ELERI JONES

IPC: C12Q1/68 ,  G06F19/20

Abstract: The present invention provides kits, methods, and apparatus for analysing a biological sample from an animal to predict (pre-symptomatically) and monitor the development of sepsis, utilising biomarker signatures, and especially biomarker signatures capable of providing a mean predictive accuracy of at least 92% to differentiate development of sepsis from non-sepsis.

Abstract translation: 本发明提供了用于分析来自动物的生物样品以预测（预症状）并监测败血症发展的试剂盒，方法和装置，利用生物标志物特征，特别是能够提供至少平均预测精度的生物标志物标记 92％以区分败血症与非败血症的发生。